epipen, mylan, fda, food and drug administration, competition, gouging, price, hike, health, health care, drug, epinephrine, cost, business, government, regulation, medicine
Latin America, Brazil, Rio Olympics, doping scandal, drug testing data, athletes’ test, hackers, Olympic event, pole vault, targeting anti-doping, WADA, World Anti-Doping Agency, Russian doping